We hereby submit Press Release for Financial Results for Q2FY27.

YH/SE/66/2026-27 November 03, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai -400001, India Symbol: YATHARTH Scrip Code: 543950 ISIN: INE0JO301016 ISIN: INE0JO301016 Sub: Press Release Dear Sir/Ma’am, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release on the Financial Results of the Company for Q2 FY27. The above Press Release will also be available on the Company’s website at https://www.yatharthhospitals.com/investors/corporate-announcements This is for your kind information and records. Thanking You Yours Faithfully, For Yatharth Hospital & Trauma Care Services Limited Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166 Encl.: A/a Press Release For Immediate Release Yatharth Hospitals Delivers Another Quarter of Strong Performance Laying a Solid Foundation for the Next Phase of Growth, with Advent Partnership Noida, November 3, 2026: Yatharth Hospital and Trauma Care Services Ltd (“the Company”) (NSE: YATHARTH, BSE: 543950), a leading private super speciality hospital chain in North India, today announced its financial results for the quarter and half year ended September 30, 2026. Financial Snapshot Particulars (Rs Mn) Q2FY27 Q2FY26 YoY (%) Q1FY27 QoQ (%) H1FY27 H1FY26 YoY (%) Revenue 4,314 2,830 52% 3,927 10% 8,241 5,423 52% EBITDA 1,020 681 50% 917 11% 1,937 1,341 44% EBITDA Margin1 23.6% 24.1% (42) bps 23.3% 30 bps 23.5% 24.7% (122) bps Cash Profits2 816 602 36% 737 11% 1,553 1,171 33% Profit After Tax 485 413 17% 454 7% 939 833 13% 1. Adjusted EBITDA Margin at 28% in Q2 FY27, excludes impact of New Delhi and Faridabad Sector-20 2. Cash Profits represent Profit After Tax plus Depreciation and Amortisation Key Highlights for the Quarter • Revenue reaches a record Rs 4,314 mn, up 52% YoY and 10% QoQ ✓ New hospitals contribute Rs 1,205 mn, contributing 28% to Group’s revenue (vs 11% in Q2 FY26), led by ramp-up across Greater Faridabad, Model Town, Faridabad Sector-20 and Agra ✓ Mature hospitals sustained strong momentum, growing 24% YoY ✓ Total Volumes grew 50% YoY; Inpatient Volumes were up by 67% YoY • Group ARPOB reaches Rs 35,948, up 11% YoY ✓ Premium NCR hospitals of Noida Extension and New Delhi approached ~Rs 50k ARPOB-mark • EBITDA reaches record Rs 1,020 mn, up 50% YoY and 11% QoQ ✓ EBITDA margins improved sequentially by 30 bps, as newer hospitals turned profitable ✓ Acquisition playbook delivering early success, as Faridabad Sector-20 and Agra stood EBITDA positive in H1; New Delhi expected to breakeven in H2 ✓ Adjusted EBITDA (excluding ramp-up impact of newer hospitals) stood at 28% • PAT at Rs 485 mn, up 17% YoY, despite higher depreciation from capacity additions ✓ Cash Profits (PAT plus depreciation) at Rs 816 mn, up 36% YoY, reflecting the underlying earnings strength of the expanded network ✓ Operating cash flow (pre-tax) of Rs 1,113 mn, up 49% YoY in H1 ✓ Total cash and bank balances stood at Rs 4,289 mn Strategic Partnership with Advent - Building the platform for the next phase • Definitive agreement with Advent International for a primary capital investment of Rs 3,150 crore through issuance of equity shares and warrants, awaiting regulatory approvals ✓ Advent to hold ~24.9% on full conversion; the Promoter family remains the largest shareholder Commenting on the performance, Mr. Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “Q2 FY2027 marks a defining milestone in Yatharth Hospitals’ growth journey. Our performance continues to reinforce the strength of our underlying business model and our ability to execute consistently. Our quarterly revenue and profits have nearly tripled since our listing in 2023, reflecting our consistent record growth quarter- over-quarter. Our acquisitions since listing have also progressed strongly, now contributing 28% of Group revenue and achieving EBITDA breakeven within a short period, underscoring our ability to successfully integrate and scale acquired assets. Our strategic partnership with Advent International represents a strong endorsement of the platform we have built, our execution capabilities and the significant growth opportunity ahead. The partnership brings together growth capital to support the acceleration of our expansion plans to ~7,000-8,000 beds over the next few years. Beyond capital, Advent brings global healthcare experience and strategic perspective that will be valuable as we scale our platform. As we embark on this next phase, we remain focused on building a larger, more integrated healthcare network while consistently delivering superior clinical outcomes, enhancing patient experience and creating sustainable long-term value for all our stakeholders.” Earnings Conference Call Wednesday, November 4, 2026 at 11:00 am IST Following the announcement of Q2 & H1 FY27 results on November 3, 2026, the management of Yatharth Hospitals will host a conference call on November 4, 2026 at 11:00 am IST, during which the management will discuss the performance and answer questions from the participants. Details of the call are given below: Conference Call Details Diamond Pass Link Link here 05:30 am UK | 01:30 pm Singapore & Hong Kong Time (other time zones) 12:30 am US East Coast | 09:30 pm US West Coast (Nov 3) +91 22 6280 1146 Universal Dial-In Numbers +91 22 7115 8047 Hong Kong: 800 964 448 Singapore: 800 101 2045 International Toll-Free Numbers UK: 0 808 101 1573 USA: 1 866 746 2133 Australia: 0080014243444 About Yatharth Hospital & Trauma Care Services Ltd: Yatharth Hospital & Trauma Care Services Limited (Yatharth Hospitals) is one of North India’s leading healthcare providers, known for delivering high-quality medical care through a network of state-of-the-art super-speciality hospitals. The Group operates a robust network across key regions including Noida, Greater Noida, Noida Extension, Greater Faridabad, Faridabad Sector-20, New Delhi and Jhansi-Orchha in Madhya Pradesh, with a growing presence in Agra and an upcoming hospital in Gurugram. With over 2,800 beds across 9 hospitals, including the upcoming Gurugram hospital, and an overall announced capacity of ~3,255 beds, Yatharth Hospitals has consistently strengthened its footprint through a combination of organic growth and strategic acquisitions. Yatharth Hospitals’ has recently announced the strategic partnership with Advent International, with a Rs 3,150 crore investments, marking one of the largest primary fund infusion by a private equity in India’s hospital sector. Disclaimer No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained is only current as of its date. Certain statements made may not be based on historical information or facts and may be “forward looking statements”, including those relating to the company’s general business plans and strategy, its future financial condition and growth prospects, and future developments in its industry and its competitive and regulatory environment. Actual results may differ materially from these forward-looking statements due to number of factors, including future changes or developments in the company’s business, its competitive environment, and political, economic, legal, and social conditions in India. Yatharth Hospital & Trauma Care Services Ltd (BSE: 543950, NSE: YATHARTH) For further information on the company, please visit https://www.yatharthhospitals.com Contact Information Corporate Office Mr. Ashutosh Kumar Jha Second Floor, Sovereign Capital Gate, FC-12 Sector 16A, Group Chief – Strategy, M&A and IR Noida, [Showing first 8,000 characters — download PDF for full document]